RT Journal Article
SR Electronic
T1 SARS-CoV-2 exposure, symptoms and seroprevalence in health care workers
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.22.20137646
DO 10.1101/2020.06.22.20137646
A1 Rudberg, Ann-Sofie
A1 Havervall, Sebastian
A1 Månberg, Anna
A1 Falk, August Jernbom
A1 Aguilera, Katherina
A1 Ng, Henry
A1 Gabrielsson, Lena
A1 Salomonsson, Ann-Christine
A1 Hanke, Leo
A1 Murrell, Benjamin
A1 McInerney, Gerald
A1 Olofsson, Jennie
A1 Andersson, Eni
A1 Hellström, Cecilia
A1 Bayati, Shaghayegh
A1 Bergström, Sofia
A1 Pin, Elisa
A1 Sjöberg, Ronald
A1 Tegel, Hanna
A1 Hedhammar, My
A1 Phillipson, Mia
A1 Nilsson, Peter
A1 Hober, Sophia
A1 Thålin, Charlotte
YR 2020
UL http://medrxiv.org/content/early/2020/06/23/2020.06.22.20137646.abstract
AB Background SARS-CoV-2 may pose an occupational health risk to health care workers, but the prevalence of infections in this population is unknown. We examined the seroprevalence of SARS-CoV-2 antibodies among health care workers at a large acute care hospital in Stockholm, Sweden. We determined correlations between seroprevalence, self-reported symptoms and occupational exposure to SARS-CoV-2.Methods and findings All employees at Danderyd Hospital (n=4375) were invited to participate in a cross-sectional study. 2149 employees from all hospital departments were enrolled in the study between April 14th and May 8th 2020. Study participants completed a questionnaire consisting of symptoms compatible with SARS-CoV-2 infection since January 2020 and occupational exposure to patients infected with SARS-CoV-2. IgG antibodies against SARS-CoV-2 were analyzed using a multiplex assay evaluated to have 99.4% sensitivity and 99.1% specificity. The over-all seroprevalence among 2149 participants was 19.1% (n=410). There was no difference in age or sex between seropositive and seronegative participants. The symptoms with the strongest correlation to seroprevalence were anosmia and ageusia, with odds ratios of 28.4 (p=2.02*10^-120) and 19.2 (p=1.67*10^-99) respectively. Seroprevalence was strongly associated with patient-related work (OR 2.9, p=4.24*10^-8), covid-19 patient contact (OR 1.43, p=0.003), and occupation as assisting nurse (OR 3.67, p=2.16*10^-9).Conclusion These results demonstrate that anosmia and ageusia should be included in screening guidance and in the recommendations of self-isolation to reduce further spread of SARS-CoV-2. The results furthermore imply an occupational health risk for SARS-CoV-2 infection among hospital workers. Continued measures are warranted to assure healthcare worker safety and reduce transmission from health care settings to the community during the covid-19 outbreak.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by Region Stockholm, Knut & Alice Wallenberg foundation, Erling-Persson family foundation, KTH Royal Institute of Technology, SciLifeLab, Christian and Jennifer Dahlberg, Atlas Copco, the Swedish Research Council, and EU grant (CoroNab).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study complied with the declaration of Helsinki, and informed consent was obtained on all participants. The study protocol was approved by the Stockholm Ethical Review Board (dnr 2020-01653).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesYes